Get the Stockscreener App
4.96
6.77%
-0.36
After Hours:
4.80
-0.16
-3.23%
Zhengye Biotechnology Holding Ltd stock is traded at $4.96, with a volume of 1.58M.
It is down -6.77% in the last 24 hours and up +17.81% over the past month.
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs and is available in 29 provincial regions across China and are exported overseas to Vietnam, Pakistan and Egypt.
See More
Previous Close:
$5.32
Open:
$5.21
24h Volume:
1.58M
Relative Volume:
9.37
Market Cap:
$252.12M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-29.34%
1M Performance:
+17.81%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$4.54
$7.35
1-Week Range:
$4.54
$7.9894
52-Week Range:
$3.90
$10.00
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Company Profile
Compare ZYBT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ZYBT
Zhengye Biotechnology Holding Ltd
|
4.96 | 252.12M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
163.50 | 72.50B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.98 | 47.08B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.16 | 45.99B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.29 | 17.52B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
312.26 | 13.78B | 2.76B | 1.11B | 898.10M | 22.77 |
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Latest News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
3 E Network Technology Group Ltd’s Quiet Period Will End on February 17th (NASDAQ:MASK) - Defense World
Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Quiet Period Set To Expire on February 17th - Defense World
Zhengye Biotech’s ‘pet-sized’ IPO leaves plenty of room for more fundraising - Bamboo Works
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters’ Over-Allotment Option - GlobeNewswire
Zhengye Biotechnology Holding Limited Announces Full Exercise of Underwriters' Over-Allotment Option - The Manila Times
Zhengye Biotechnology Holding Limited Announces Closing of Initial Public Offering - GlobeNewswire
ZYBT IPO NewsChinese animal health company Zhengye Biotechnology prices US IPO at the $4 low end - Renaissance Capital
Chinese vaccine maker Zhengye Biotechnology prices IPO at $4 per share - MSN
Zhengye Biotechnology Holding Limited Announces Pricing of Initial Public Offering - GlobeNewswire
Zhengye Biotechnology Holding Limited (ZYBT) to Raise $7 Million in IPO - Defense World
ZYBT News Today | Why did Zhengye Biotechnology stock go down today? - MarketBeat
Chinese animal health company Zhengye Biotechnology ups share offering by 20% ahead of $7 million US IPO - renaissancecapital.com
InvestorsHubNYSE, NASDAQ, AMEX, OTCBB, Pink Sheet Stock Message Boards, Stock Charts, Stock Quotes, Level II and Market News - Investors Hub
Zhengye Biotechnology Holding Ltd Stock (ZYBT) Financials Data
There is no financial data for Zhengye Biotechnology Holding Ltd (ZYBT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
4.06%
0.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):